Department of Nephrology, University of Heidelberg, INF Heidelberg, Germany.
Transplantation. 2010 Oct 15;90(7):771-6. doi: 10.1097/TP.0b013e3181f009ef.
Chronic loss of renal allograft function is associated with interstitial fibrosis and tubular atrophy (IF/TA). Independent of the underlying reason, one initial step in the development of fibrosis is chemokine-driven invasion of leukocytes from the blood vessels into the allograft. We studied the role of chemokines in kidney allografts with delayed graft function and the subsequent long-term outcome of renal function and fibrosis.
We examined repetitive biopsies of 30 patients without signs of acute rejection but with initially delayed graft function for IF/TA. In addition, we examined the expression of chemokine receptor (CCR)-1 and CCR2 on invaded leukocytes and macrophages and the corresponding ligands regulated upon activation, normal t-cell expressed, and secreted (RANTES) and monocyte chemotactic protein-1 on residential kidney cells.
The initial expression of CCR1 positive invading cells and RANTES in glomerular cells correlated with the allograft function 12 months after transplantation and at last follow-up. The expression was independent of donor characteristics such as age, gender, infectious state, cause of death, or use of vasopressive agents. Furthermore, it did not correlate with the duration of cold ischemia time. Among the patients with the most progressive loss of allograft function follow-up biopsy specimen did not reveal any signs of rejection but showed increased CCR1 and RANTES expression in the interstitium suggesting ongoing inflammation and fibrosis.
An early expression of RANTES in renal allografts with delayed graft function with consecutive invasion of CCR1 positive cells seems to promote ongoing IF/TA and to worse renal allograft outcome.
慢性肾移植功能丧失与间质纤维化和肾小管萎缩(IF/TA)有关。无论潜在原因如何,纤维化发展的初始步骤之一是趋化因子驱动白细胞从血管侵入移植物。我们研究了趋化因子在伴有延迟移植物功能的肾移植中的作用以及随后肾功能和纤维化的长期结局。
我们检查了 30 名无急性排斥迹象但最初有延迟移植物功能的患者的重复活检,以检查 IF/TA。此外,我们还检查了浸润白细胞和巨噬细胞上趋化因子受体(CCR)-1 和 CCR2 的表达,以及常驻肾细胞上调节活化正常 T 细胞表达和分泌(RANTES)和单核细胞趋化蛋白-1 的相应配体。
初始表达 CCR1 阳性浸润细胞和 RANTES 在肾小球细胞中与移植后 12 个月和最后一次随访时的移植物功能相关。表达与供体特征无关,如年龄、性别、感染状态、死因或使用血管加压药物。此外,它与冷缺血时间的长短无关。在移植功能进行性丧失最严重的患者中,活检标本未显示任何排斥迹象,但间质中 CCR1 和 RANTES 的表达增加,提示持续存在炎症和纤维化。
延迟移植物功能的肾移植中 RANTES 的早期表达,伴有 CCR1 阳性细胞的连续浸润,似乎促进了持续的 IF/TA 和更差的肾移植结局。